Testing the efficacy of antisecretory drugs in patients with haematemesis and melaena.
Despite the logical expectation of effectiveness, and wide use, of antisecretory drugs in the initial management of patients with hematemesis and melaena, convincing evidence of benefit is lacking.
Department of Medicine, Queen Elizabeth Hospital, Birmingham, United Kingdom.
M J
MJ
Langman
D006396:Hematemesis / Q000188:drug therapy*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008551:Melena / Q000188:drug therapy*; D015201:Meta-Analysis as Topic; D009853:Omeprazole / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D012107:Research Design; D013004:Somatostatin / Q000627:therapeutic use
D006635:Histamine H2 Antagonists; D013004:Somatostatin; D009853:Omeprazole